Analyst Ratings for Contineum Therapeutics (CTNM)
CTNM Rating Summary
CTNM Price Target Summary
- Highest: $30.00 (Jones Trading)
- Lowest: $14.00 (Baird)
- Average: $22.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$22.00 (+210.7%)
* Over Last 12-Mos
Rating Score: 5.7 / 10
Percentile Rank: 60%
Avg. $ Target:
$22.00 (+210.7%)
* Over Last 12-Mos
Rating Score: 5.7 / 10
Percentile Rank: 60%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/13/2026 | Baird | Joel Beatty | Downgrade | Neutral (Outperform) |
14.00 (19.00) |
8.57 (7.08) |
-17.39% | Details |
| 9/24/2026 | Goldman Sachs | Andrea Newkirk | New Coverage | Early-Stage Biotech (N/A) |
N/A (N/A) |
13.40 (7.08) |
-47.16% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
